HAE
Price
$93.39
Change
+$1.13 (+1.22%)
Updated
May 2, 6:59 PM EST
6 days until earnings call
RXST
Price
$59.63
Change
+$2.93 (+5.17%)
Updated
May 2, 6:59 PM EST
3 days until earnings call
Ad is loading...

Compare trend and price HAE vs RXST

Header iconHAE vs RXST Comparison
Open Charts HAE vs RXSTBanner chart's image
Haemonetics
Price$93.39
Change+$1.13 (+1.22%)
Volume$87.18K
CapitalizationN/A
RxSight
Price$59.63
Change+$2.93 (+5.17%)
Volume$251.38K
CapitalizationN/A
View a ticker or compare two or three
HAE vs RXST Comparison Chart

Loading...

HAEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RXSTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
HAE vs. RXST commentary
May 03, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HAE is a Buy and RXST is a Hold.

COMPARISON
Comparison
May 03, 2024
Stock price -- (HAE: $93.33 vs. RXST: $59.63)
Brand notoriety: HAE and RXST are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: HAE: 78% vs. RXST: 163%
Market capitalization -- HAE: $4.33B vs. RXST: $1.91B
HAE [@Medical Specialties] is valued at $4.33B. RXST’s [@Medical Specialties] market capitalization is $1.91B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HAE’s FA Score shows that 0 FA rating(s) are green whileRXST’s FA Score has 0 green FA rating(s).

  • HAE’s FA Score: 0 green, 5 red.
  • RXST’s FA Score: 0 green, 5 red.
According to our system of comparison, RXST is a better buy in the long-term than HAE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HAE’s TA Score shows that 4 TA indicator(s) are bullish while RXST’s TA Score has 6 bullish TA indicator(s).

  • HAE’s TA Score: 4 bullish, 4 bearish.
  • RXST’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, RXST is a better buy in the short-term than HAE.

Price Growth

HAE (@Medical Specialties) experienced а +6.47% price change this week, while RXST (@Medical Specialties) price change was +14.92% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.01%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was +12.85%.

Reported Earning Dates

HAE is expected to report earnings on Aug 06, 2024.

RXST is expected to report earnings on Aug 05, 2024.

Industries' Descriptions

@Medical Specialties (+1.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for HAE with price predictions.
OPEN
A.I.dvisor published
a Summary for RXST with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
HAE($4.34B) has a higher market cap than RXST($1.91B). HAE has higher P/E ratio than RXST: HAE (34.47) vs RXST (15.27). RXST YTD gains are higher at: 47.892 vs. HAE (9.145). HAE has higher annual earnings (EBITDA): 264M vs. RXST (-41.04M). HAE has more cash in the bank: 194M vs. RXST (127M). RXST has less debt than HAE: RXST (3.01M) vs HAE (871M). HAE has higher revenues than RXST: HAE (1.27B) vs RXST (89.1M).
HAERXSTHAE / RXST
Capitalization4.34B1.91B227%
EBITDA264M-41.04M-643%
Gain YTD9.14547.89219%
P/E Ratio34.4715.27226%
Revenue1.27B89.1M1,425%
Total Cash194M127M153%
Total Debt871M3.01M28,918%
FUNDAMENTALS RATINGS
HAE: Fundamental Ratings
HAE
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
91
SMR RATING
1..100
59
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
71
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HAERXST
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
61%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
58%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 15 days ago
60%
Bearish Trend 9 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
70%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
HAEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RXSTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LIT45.631.57
+3.56%
Global X Lithium & Battery Tech ETF
FMET28.150.59
+2.15%
Fidelity Metaverse ETF
BIBL36.660.43
+1.19%
Inspire 100 ETF
FPAG28.110.29
+1.04%
FPA Global Equity ETF
ZSC24.120.13
+0.55%
USCF Sustainable Commodity Strategy

RXST and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXST has been loosely correlated with AXNX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if RXST jumps, then AXNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXST
1D Price
Change %
RXST100%
+5.17%
AXNX - RXST
46%
Loosely correlated
+0.36%
ATEC - RXST
43%
Loosely correlated
+1.85%
TMDX - RXST
40%
Loosely correlated
+5.82%
VCYT - RXST
40%
Loosely correlated
+0.30%
PEN - RXST
39%
Loosely correlated
+0.38%
More